# Odyssey Thera

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/odyssey-thera

- Industry: Biotechnology
- Headquarters: San Ramon, US
- Website: www.odysseythera.com
- Total disclosed funding: $26M
- Latest round: Series A (Oct 1, 2008)
- Investors on record: 6

## About

Odyssey Thera Inc. is a company focused on providing a unique domain for sale, targeting various sectors. Their offering supports businesses in establishing an online presence, enhancing engagement with end-users through customized web services.Founded in 2000 and headquartered in San Ramon, US, Odyssey Thera Inc. specializes in the sale of domain names. The firm has completed a total of 9 deals, with the most recent funding round occurring on February 14, 2013. HBM Partners and Burrill & Company invested USD 2.80 mn in this round, which is the total amount raised by the company. The founder's history is not detailed in available information.OdysseyThera.com offers a domain name for sale, which serves as a versatile online asset for businesses across various industries, including healthcare, technology, and consumer goods. It can be utilized for e-commerce sites, blogs, and corporate platforms, assisting clients in establishing a robust digital footprint globally.The revenue model revolves around the sale and potential lease of the domain name, priced at USD 6,395 or via a payment plan of USD 266.46 per month for 24 months. Clients can quickly access the domain upon acquisition, with a streamlined purchasing process that includes a 30-day money-back guarantee, ensuring customer satisfaction.The recent funding received on February 14, 2013, will support the company’s strategy to enhance its domain offerings and potentially introduce new products in the future. Odyssey Thera Inc. is focused on expanding its market reach, particularly targeting specific sectors for growth, although detailed geographical targets or new product timelines have not been disclosed.

## Funding rounds

- Series A, Oct 1, 2008, $11M — Burrill & Company, HealthCap, HBM Partners, Merck & Co., Inc.
- Series B, Jun 24, 2002, $15M — Burrill & Company, HealthCap, HBM Partners, Cogene Ventures, Targeted Technology

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series B, Series A
- HealthCap — Series B, Series A
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B, Series A
- Cogene Ventures (https://capitalatlas.ai/funds/cogene-ventures) — Series B
- Targeted Technology (https://capitalatlas.ai/funds/targeted-technology) — Series B
- Merck & Co., Inc. — Series A